Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co‐morbid burden in acute decompensated heart failure

AIMS: Co‐morbidities are associated with poor clinical outcomes in patients with chronic heart failure, while cardiac iodine‐123 (I‐123) metaiodobenzylguanidine (MIBG) imaging provides prognostic information in such patients. We sought to prospectively investigate the incremental prognostic value of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayama, Kiyomi, Yamada, Takahisa, Tamaki, Shunsuke, Watanabe, Tetsuya, Morita, Takashi, Furukawa, Yoshio, Kawasaki, Masato, Kikuchi, Atsushi, Kawai, Tsutomu, Seo, Masahiro, Nakamura, Jun, Kawahira, Masatsugu, Fukunami, Masatake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006734/
https://www.ncbi.nlm.nih.gov/pubmed/33438366
http://dx.doi.org/10.1002/ehf2.13173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006734/
https://www.ncbi.nlm.nih.gov/pubmed/33438366
http://dx.doi.org/10.1002/ehf2.13173

Ejemplares similares